141 related articles for article (PubMed ID: 20192676)
1. Erythropoietin and subarachnoid hemorrhage.
Grasso G; Sfacteria A
J Neurosurg; 2010 Mar; 112(3):699-700. PubMed ID: 20192676
[No Abstract] [Full Text] [Related]
2. Erythropoietin for subarachnoid hemorrhage: is there a reason for hope?
Grasso G; Tomasello F
World Neurosurg; 2012 Jan; 77(1):46-8. PubMed ID: 22079816
[No Abstract] [Full Text] [Related]
3. Effects of erythropoietin.
Gu YL; Zhao ZX
J Neurosurg; 2014 Jan; 120(1):293-4. PubMed ID: 24180572
[No Abstract] [Full Text] [Related]
4. In vivo evidence that erythropoietin has a neuroprotective effect during subarachnoid hemorrhage.
Buemi M; Grasso G; Corica F; Calapai G; Salpietro FM; Casuscelli T; Sfacteria A; Aloisi C; Alafaci C; Sturiale A; Frisina N; Tomasello F
Eur J Pharmacol; 2000 Mar; 392(1-2):31-4. PubMed ID: 10748269
[TBL] [Abstract][Full Text] [Related]
5. The neuroprotective role of erythropoietin in the management of acute ischaemic stroke: from bench to bedside.
Ntaios G; Savopoulos C; Chatzinikolaou A; Hatzitolios AI
Acta Neurol Scand; 2008 Dec; 118(6):362-6. PubMed ID: 18513348
[TBL] [Abstract][Full Text] [Related]
6. Endothelial nitric oxide-mediated Nrf2 activation as a novel mechanism for vascular and neuroprotection by erythropoietin in experimental subarachnoid hemorrhage.
Genc S; Egrilmez MY; Genc K
Med Hypotheses; 2006; 67(2):424. PubMed ID: 16707229
[No Abstract] [Full Text] [Related]
7. Erythropoietin for the treatment of subarachnoid hemorrhage: a review.
Turner JD; Mammis A; Prestigiacomo CJ
World Neurosurg; 2010 May; 73(5):500-7. PubMed ID: 20920933
[TBL] [Abstract][Full Text] [Related]
8. Effect of recombinant human erythropoietin on cerebral ischemia following experimental subarachnoid hemorrhage.
Alafaci C; Salpietro F; Grasso G; Sfacteria A; Passalacqua M; Morabito A; Tripodo E; Calapai G; Buemi M; Tomasello F
Eur J Pharmacol; 2000 Oct; 406(2):219-25. PubMed ID: 11020484
[TBL] [Abstract][Full Text] [Related]
9. A neuroprotective derivative of erythropoietin that is not erythropoietic.
Doggrell SA
Expert Opin Investig Drugs; 2004 Nov; 13(11):1517-9. PubMed ID: 15500399
[TBL] [Abstract][Full Text] [Related]
10. Trial design in "magnesium sulphate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial".
Wong GK; Boet R; Poon WS; Chan MT
Stroke; 2005 Dec; 36(12):2530-1; author reply 2531-2. PubMed ID: 16282545
[No Abstract] [Full Text] [Related]
11. Erythropoietin and subarachnoid hemorrhage.
Niemelä M; Niemi T; Hernesniemi J
World Neurosurg; 2010 May; 73(5):461-2. PubMed ID: 20920923
[No Abstract] [Full Text] [Related]
12. Intranasal erythropoietin therapy in nervous system disorders.
Genc S; Zadeoglulari Z; Oner MG; Genc K; Digicaylioglu M
Expert Opin Drug Deliv; 2011 Jan; 8(1):19-32. PubMed ID: 21143002
[TBL] [Abstract][Full Text] [Related]
13. From pharmacological promises to controlled clinical trials to meta-analysis and back: the case of nimodipine in cerebrovascular disorders.
Di Mascio R; Marchioli R; Tognoni G
Clin Trials Metaanal; 1994 Apr; 29(1):57-79. PubMed ID: 10150186
[TBL] [Abstract][Full Text] [Related]
14. Molecular targets for ameliorating early brain injury post subarachnoid hemorrhage: a new focus.
Bhardwaj A
Crit Care Med; 2010 Feb; 38(2):727-8. PubMed ID: 20083949
[No Abstract] [Full Text] [Related]
15. Erythropoietin: will it improve outcome after subarachnoid hemorrhage?
Macdonald RL
World Neurosurg; 2010 May; 73(5):463-4. PubMed ID: 20920924
[No Abstract] [Full Text] [Related]
16. Guidelines for the use of recombinant human erythropoietin.
Barosi G; Cazzola M; De Vincentiis A; Grossi A; Tura S
Haematologica; 1994; 79(6):526-33. PubMed ID: 7896210
[No Abstract] [Full Text] [Related]
17. Glibenclamide in aneurysmatic subarachnoid hemorrhage (GASH): study protocol for a randomized controlled trial.
da Costa BBS; Windlin IC; Koterba E; Yamaki VN; Rabelo NN; Solla DJF; Teixeira MJ; Figueiredo EG
Trials; 2019 Jul; 20(1):413. PubMed ID: 31288831
[TBL] [Abstract][Full Text] [Related]
18. Short-term Tolerance of Nasally-administered NeuroEPO in Patients with Parkinson Disease.
García-Llano M; Pedroso-Ibáñez I; Morales-Chacón L; Rodríguez-Obaya T; Pérez-Ruiz L; Sosa-Testé I; Amaro-González D; Bringas-Vega ML
MEDICC Rev; 2021 Jan; 23(1):49-54. PubMed ID: 33780423
[TBL] [Abstract][Full Text] [Related]
19. Recombinant Human Milk Fat Globule-Epidermal Growth Factor 8 Attenuates Microthrombosis after Subarachnoid Hemorrhage in Rats.
Wang J; Zuo Y; Zhuang K; Luo K; Yan X; Li J; Zhang JH; Liu F
J Stroke Cerebrovasc Dis; 2020 Mar; 29(3):104536. PubMed ID: 31883781
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietin prevents delayed hemodynamic dysfunction after subarachnoid hemorrhage in a randomized controlled experimental setting.
Güresir E; Vasiliadis N; Konczalla J; Raab P; Hattingen E; Seifert V; Vatter H
J Neurol Sci; 2013 Sep; 332(1-2):128-35. PubMed ID: 23907045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
